Anat Naschitz

Managing Director at OrbiMed, the world’s largest healthcare investment firm with over $11 billion under management across public and private asset classes.

Serves on the boards of Treato – patient big data analytics, Tyto – mobile telemedicine device – and Medigus – surgical endoscopy.

Previously Associate Partner at McKinsey & Company in London, managing strategy and M&A projects for senior management of the world's preeminent pharmaceutical and biotechnology companies. Among other accomplishments, Anat led pharmaceutical spinout work resulting in the creation of two European biotech companies, which subsequently had IPOs for over $1 billion.

Post McKinsey she joined Apax Partners, where she focused on life sciences investments. Subsequently Anat served as a director/advisor to the boards of life science companies and investors.

She earned her M.B.A. at INSEAD and her LL.B. at Tel Aviv University.